| Nycomed launched as merged group | Posted on 18/01/2007 in Pharmaceutical Company Restructures Nycomed has this week announced the launch of the combined Nycomed group, following the company's acquisition of Altana Pharma. Nycomed finalised the acquisition of Altana on December 31st 2006 and is now focusing its efforts on fully integrating the companies, with today's announcement marking the start of these efforts.
Steps taken by the company to start the integration include the appointment of the executive committee and country managers, in addition to the team which shall oversee the process of integration.
Forthcoming moves to further this merging include the establishment of a new corporate headquarters in Zurich by May and the defining of the overall structure of the group's local operating companies and corporate functions.
Hakan Bjorklund, chief executive officer of Nycomed, said: "Our primary concern is patient welfare, so we will maintain focus on being a responsive and reliable partner for our customers.
"We're 100 per cent dedicated to meeting our commitments and continuing to provide the high level of service that people rightly expect."
He added that while the merger was progressing according to schedule, Nycomed was in the first phase of this restructuring of the company.
Nycomed announced that it had signed an agreement for the acquisition of Altana Pharma on September 21st 2006, with regulatory bodies approving the deal on December 14th and a majority of shareholders giving their backing at a meeting five days later.Other news stories from 18/01/2007
Read more in the Zenopa News Archive
How this news is generated
|  |
|
